chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she has a friend that works for Pfizer that she reported the patient's positive Covid-19 test post vaccination to.; she reported the patient's positive Covid-19 test post vaccination to; This is a spontaneous report received from a contactable consumer (patient's friend). This consumer reported similar events for five patients. This is the one of five reports.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 07Jan2021 at 10:00 (Batch/Lot Number: EL0142) as single dose; dose 1 via an unspecified route of administration, administered in Arm Left on 17Dec2020 at 11:00 (Batch/Lot Number: EK5730) as single dose; both for covid-19 immunisation. Medical history included ongoing ADD (attention deficit hyperactivity disorder; diagnosed probably about 19 years ago). Concomitant medications included dextroamphetamine(DEXAMFETAMINE) taken for ADD (attention deficit hyperactivity disorder) from an unspecified start date and ongoing at 30mg twice a day. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's friend reported that she has a friend that works for Pfizer that she reported the patient tested positive for Covid-19 test post vaccination. The patient was tested for Covid-19 on 26Feb2021. The patient was made aware of the positive result on 28Feb2021 and developed symptoms of Covid-19 on 26Feb2021, and that the patient went back to work on 12Mar2021. The patient's friend stated that she believed the patient experienced symptoms of Covid-19 until 10Mar2021. The patient's friend reported that of the 16 individuals that tested positive for Covid-19, four had been vaccinated, which was why the caller was wondering if maybe there had been a bad batch of the product. The patient did not visit any emergency room and physician office. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 26Feb2021. The patient recovered from the events on 10Mar2021.  Additional information has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331780 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331805 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331806 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331807 Same reporter and drug with lack of effect; different patient
Weird rash on the left arm, not on the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Weird rash on the left arm, not on the injection site.) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Weird rash on the left arm, not on the injection site.). The patient was treated with PARACETAMOL (TYLENOL) for Paracetamol, at an unspecified dose and frequency. At the time of the report, RASH (Weird rash on the left arm, not on the injection site.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.    Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: No specific follow-up information recorded.
I am getting  progressive increasing spontaneous  bruising on my right upper arm. These bruises appear without any injury to my arm at all.
pt recv vax; pt's lt hip reacted to vax; was itchy, red & swollen;
temperature excursion due to a power outage, normal fridge temperature stays around 41 F, the temperature was 49 F when they discovered the vaccines after the power outage, with no reported adverse event; The FLUZONE HD QIV has been administered post excursion, with no reported adverse event; Initial information received on 07-Nov-2022 regarding an unsolicited valid non-serious case received from a healthcare professional.  This case involves a 65-year-old male patient to whom INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] has been administered post excursion and temperature excursion due to a power outage, normal fridge temperature stays around 41 F, the temperature was 49 F when they discovered the vaccines after the power outage, with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 07-Nov-2022, the patient received 0.7 ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (formulation, strength: unknown) (lot number: UJ919AD and expiry date: 30-Jun-2023) via intramuscular route in the right deltoid for Immunization and it has been administered post excursion, with no reported adverse event (poor quality product administered) (latency: same day) and temperature excursion due to a power outage, normal fridge temperature stays around 41 f, the temperature was 49 f when they discovered the vaccines after the power outage, with no reported adverse event (product storage error.  It was reported, they are not sure what the temperature reached over the weekend. They are not sure if the temperature went any higher than that. They were told that the power was out for approximately 6 hours. This situation is reported as a medication error due to temperature excursion that exceeded the stability data documented in the local labelling and additional supporting stability data. This situation is reported as a medication error due to the possible inappropriate administration of FLUZONE HD QIV to a patient post excursion.  Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) was not applicable.  At time of reporting, the outcome was Unknown for both events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient's daughter presented to the pharmacy on 6/19/2019 to pick up an antibiotic for the patient. After talking to the daughter, she said that her mother was dealing with side effects of getting the Prevnar vaccine on 6/13/2019. The daughter explained that her mother was having soreness, redness, fever,  and had a swollen upper arm. The daughter explained that she had taken her mother to see her doctor this morning (6/19/2019) and he prescribed an antibiotic. The daughter also noted that her mother has had a left side mastectomy and had been given the vaccine on her left arm.
Has rash on the same arm of injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (Has rash on the same arm of injection) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Has rash on the same arm of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (Has rash on the same arm of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Contains non significant information.
Severe Shingle type Pain in exact area Shingles had erupted 7 months prior lasting 10 days. TX. Pain meds and patches.
Fever, Chills, Severe shaking, headache, loss of appetite, tired, sleeping most of the day. This lasted for 2 days. This also occurred after the 1st vaccination as well.
Issued four vaccinations at 1630. At 1634, patient passed out and when lowered to lay down, patient began convulsing for approx. 30 seconds. Patient became flushed and began drooling. Elevated legs and called MD.
Shortly after receiving the first dose of Covid-19 vaccine from Pfizer the patient complains of severe itchy rash/ hives all over his body- worse on his back but all over.  The rash has continued since the intial vaccine and got worse after going elsewhere for next vaccine. The patients doctor has done a thorough medical exam and has been unable to determine the cause of the rash. The doctor feels it is an autoimmune reaction to the vaccine. Treated with various oral medications and topical treatments which do seem to "calm down" the severe itching but hives are still there.
nausea, vomit & fever of 104;adm to hosp for IV fluids & meds;treated w/ATB & recovered;all lab work-nl;
Approximately 48 hours after the injection, I experienced arm pain. Pain radiated from behind my neck, down through my arm to my elbow. This lasted for about a week and then stopped. Also about this time, I have been experiencing a buzzing in my ears. It sounds like buzzing power lines. I have always had super hearing, so this is brand new. The ringing has been ongoing for almost two weeks.
ARM PAIN; SOME CHILLS; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient never got covid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced arm pain, some chills, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm pain, some chills, and fatigue. This report was non-serious.
days ago, which was just an small area on the leg. Pt recieved varicella, hep B, IPV, menactra and Tdap vaccines about 3 days later on 8/21. As of 1 day ago, the rash has worsened, and is now on the upper legs, arms and both hands, and back. She has been trying clamine, tecnu ointment, and just started triamcinolone 0.1% cream today. She has been using benadryl once a day which seems to help with the itching some. It has not been oozing. It is itchy but not painful.
Dark urine post-vaccination on first void and on second void 2 hours later followed by severe bilateral flank pain that lasted approximately 48 hours following vaccination.
Developed temp 104.6, irritable, crying, rash.  Mom states child had a mild seizure, had a history of seizure in past when had increased temp. Dx =  had a viral infection.
Sun 2/21 - fever (101.1), site of injection soreness, body aches, joint aches, headache, fatigue, loss of appetite. Mon 2/22 - same as Sunday 2/21 but fever came down to 100.1 and symptoms were generally milder Tues 2/23 - better in general and fever broke during early hours of morning. Most symptoms still present but milder Wed 2/24 11:30am mild breathing difficulty began and at 1 pm inhaler was used.  Breathing difficulty subsided (but not fully restored)until @7pm and 1st nebulizer treatment was done. Breathing difficulty subsided (but not fully restored) until @10:45pm and 2nd nebulizer treatment was done. Hands were noticed to have purple coloring prior this nebulizer treatment. Thurs 2/25 7:00am breathing was labored and became difficult by 8:30am and was taken to emergency room for evaluation and treatment.
Breakthrough case admission after 2 vaccines Pfizer 2/19/21 Lot# EM9810; Pfizer 3/12/21 Lot# EN6207
Fever of 102.1, chills, body aches, nausea, headache, lethargy.
INJECTION SITE WARMTH; INJECTION SITE RASH ABOUT 3 TO 4 INCHES LONG 1 INCH WIDE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced injection site warmth, and injection site rash about 3 to 4 inches long 1 inch wide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from injection site rash about 3 to 4 inches long 1 inch wide, and the outcome of injection site warmth was not reported. This report was non-serious.
After approximately a half hour, I felt my left eye above the eye on the lid and the white part of my eye  begin to swell. After another half hour or so, I  could feel it swelling and it was noticable. I called my eye doctor and was advised  me on an over the counter eye drop.
3 days p/inj upper arm hot red & swollen lasting 4 days;6APR rash on back which spread head to toe;no fever;had h/a, nausea, anorexia, malaise;10APR notice joint swelling & aches hands, fingers, elbows, ankles;
Body aches, headache starting at 10:00 pm and persisting through the following evening (approximately 24 hours)
Patient was getting her 2nd dose of the SHINGRIX vaccine (1st dose was 4/19/2018). Later the same day, she had chills and flu-like symptoms. She started to feel better the next day but was still "achy."
Pt is immunocompromised. Vomiting began evening after vaccine (PNEUMOVAX) was given. Vaccine administered 12/15/18 at 10:00am. Pt's partner called 12/16/18 to notify me he was going to hospital due to vomiting.
11/17/2006 started with numbness in both feet L>R by 11/30/06 progressed to both arms. C/o extreme pain between shoulders. Transferred to Hospital neurology. Received 3 treatments of IgG. 12/15/06 Received medical records from hospital which reveal patient had been admitted for 1 day & transferred from outlying hospital on 11/24/06 w/severe back pain for approx 1 week with weakness of all extremities.  Received flu shot 11/1/06.  Neuro exam in ER revealed absent reflexes bilaterally at ankles, knees, biceps, triceps & brachioradialis tendons.  EMG testing done in ER strongly suggestive of GBS.  Treated w/steroids & IVIG.  Improved slowly & was to receive inpatient rehab.  Prognosis was felt to be quite good.  HTN diagnosed with this admission. Final Dx: Guillain Barre Syndrome. 12/18/06 Received D/C summary from hospital.  Pt admitted 11/24/06 & d/c to home on 12/5/06, ambulatory but still weak with improved forced vital capacity  (from 2.2L to 3.9L) Information received from the annual follow up indicates recipient has not recovered. Still lacks some upper body strength, has difficulty with his balance when tired, some fine motor difficulties in his hands and numbness and tingling in his feet. He is back to his full time work. 3/31/10 Follow up: He is still experiencing pain in his back. (Uses Duragesic Patch). He has numbness in his fingers and feet. He descrubes it as "walking on pins." Has been unable to return to his work.
1. Left arm has the throbbing pain ( Pins and Needles) , intermittent but very painful.  2. feels like electric current through all arm all the way to the hand.  3. After 4 days of injection, pain is still present, pain killer doesn't help
Lungs were burning and heart felt weird when I got home from work. I had a fever, sweating, body aches and chills later that day and also while sleeping that night. A few days later I broke out with a red rash in my armpits.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 23-JAN-2017, the patient was vaccinated with an improperly stored dose of VARIVAX lot number M033906, expiration date 20-JUL-2018 (dose, route and anatomical location were not reported) for prophylaxis (incorrect product storage). The vaccine was exposed to temperature of -5 Fahrenheit (F) (-20 Celsius (C)) and to the lowest recorded temperature of -14 F (-25C) during 4 hours and 5 minutes. The storage type was reported as "data logger". There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested. Sender's Comments: US-009507513-1701USA012890: US-009507513-1701USA013083: US-009507513-1701USA013084: US-009507513-1701USA013085: US-009507513-1701USA013086: US-009507513-1701USA013087: US-009507513-1701USA013088: US-009507513-1701USA013089: US-009507513-1701USA013091: US-009507513-1701USA013090: US-009507513-1701USA013092: US-009507513-1701USA013093: US-009507513-1701USA013094: US-009507513-1701USA013095: US-009507513-1701USA013096: US-009507513-1701USA013097: US-009507513-1701USA013098: US-009507513-1701USA013099: US-009507513-1701USA013100: US-009507513-1701USA013101: US-009507513-1701USA013102: US-009507513-1701USA013103: US-009507513-1701USA013104: US-009507513-1701USA013105: US-009507513-1701USA013106: US-009507513-1701USA013107: US-009507513-1701USA013108: US-009507513-1701USA013109: US-009507513-1701USA013110: US-009507513-1701USA013082.
pt recvd vax; leukocytosis vasculitis p/ 1 day; punch biopsy done;
This case was forwarded by Crucell, no: CVAE-044-2012. An initial report was received from a nurse on 28.Nov.2012 and concerns a 17-year-old female patient, who on 28.Nov.2012 received the first oral dose of VIVOTIF (batch no,: 3000220). Medical history was not reported. Concomitant medication included an unspecified birth control mediation. On 28.Nov.2012, at an early time, the patient took the vaccination on an empty stomach. 5 hours later, the patient are pasta and experienced severe cramping. At the time of reporting, the patient had not yet recovered. The event was considered non-serious.
When our facility received the Covid - 19 vaccine,  and was told that the exp. date for the vaccine was 9 months from the mfg. date on the box. Which made the exp. date 5/31/22. On 5/20/22 Contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 5/2/22. Thus we unknowingly gave exp vaccine to patient.   Patient tolerated vaccine well, no adverse effects have been reported.
On the first day, after about 12 hours I started having severe muscle aches, especially legs, feet, and shoulders. The symptoms continued for the next 12 hours and then they largely went away. For the next week I had a mild headache, and after 6 days I had a strong pain the left eye, with burning like sensation. It was accompanied by tingling in the left check,  left forearm and left leg. After a day the pain decreased, but over the next week I've been getting spontaneous tingling and itching in palms, left arm, and lower parts of the legs (mostly calves and feet). Now the eye pain mostly disappeared, I get an acute pain in the left ear that occurs randomly, lasts for about 30-60 seconds and goes away.
Swelling and redness at injection site.  Seen by Nurse Practitioner and placed on Bactrim on 11/11/13.  Will rtc for follow up appt on 11/12/13.
tested positive for covid; cough; muscle pain; Fever; very week; This spontaneous report was reported by an other health care professional and describes the occurrence of MYALGIA (muscle pain), ASTHENIA (very weak), COVID-19 (tested positive for covid), COUGH (cough) and PYREXIA (Fever) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient had no medical history     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (muscle pain), ASTHENIA (very weak), COUGH (cough) and PYREXIA (Fever). On 19-Jan-2021, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, MYALGIA (muscle pain), ASTHENIA (very weak), COVID-19 (tested positive for COVID) and COUGH (cough) outcome was unknown.  The outcome for the patient being tested with COVID-19 is unlikely because of the vaccine.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Per EMS, the patient was last seen walking and talking to wife 10 minutes prior to EMS arrival. EMS reports via patients wife, that patient was upstairs to change for his doctor appointment then patient's wife found him down. The patient received his COVID-19 vaccine on 1/25/21. EMS states they gave 5 rounds of EPI then patient moved into vfib then was shocked once but returned to asystole. In ED, the patient initially in asystole CPR was started immediately. The patient was given 3 rounds EPI, 1 round bicarb. The patient stayed in PEA throughout. Patient was given tPA. Patient continued to be in asystole and time of death was called at 11:35 am.
A physician reported that a patient received 3 doses of Hib-Titer and died from "H. Influenza meningitis". The physician declined to provide additional information.
her arm was sore; chills; body aches; nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (her arm was sore), CHILLS (chills), MYALGIA (body aches) and NAUSEA (nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3001176) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (her arm was sore), CHILLS (chills), MYALGIA (body aches) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (her arm was sore), CHILLS (chills), MYALGIA (body aches) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  No Relevant concomitant medications was reported.  Treatment information was not provided.
pt recv vax 27DEC95 & 26APR96 pt devel rash w/30-40 lesions;the exp was dx as active chicken pox;MD reported 3 patients w/the same exp;
The patient was given the MENACTRA and HPV vaccines and asked to wait 15 min. afterwards. Approximately 5 min after receiving the vaccines the mother started yelling for help. The patient appeared to being having a seizure and was very stiff in the limbs. The patient was laid down and came around almost immediately. Pulse was 72, BP 100/70, P ox, 68. Given some candy and water and asked to lay down. An ice pack was applied to the head due to hitting it when seizing. About 20 min. later the patient walked out of the clinic on her own after being evaluated by a MD.
hypoxia, SpO2 68% on room air, cough and diarrhea
Prolonged arm pain, swollen neck, numbness and tingling (currently going on 6 weeks)